GRACELL BIOTECHNOLOGIES INC

CUSIP: 38406L103 Class: ADR

ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 9,308,726 Value ($000) $93,460 Avg Close — Range —
Q3 2023
Shares 9,308,726 Value ($000) $26,809 Avg Close — Range —
Q2 2023
Shares 9,033,726 Value ($000) $34,418 Avg Close — Range —
Q1 2023
Shares 9,497,774 Value ($000) $17,666 Avg Close — Range —
Q4 2022
Shares 7,884,870 Value ($000) $18,135 Avg Close — Range —
Q3 2022
Shares 7,884,870 Value ($000) $25,389 Avg Close — Range —
Q2 2022
Shares 7,884,870 Value ($000) $43,367 Avg Close — Range —
Q1 2022
Shares 7,884,870 Value ($000) $18,372 Avg Close — Range —
Q4 2021
Shares 7,884,870 Value ($000) $47,625 Avg Close — Range —
Q3 2021
Shares 7,884,870 Value ($000) $109,363 Avg Close — Range —
Q2 2021
Shares 7,884,870 Value ($000) $102,503 Avg Close — Range —
Q1 2021
Shares 7,884,870 Value ($000) $121,427 Avg Close — Range —